Tenet Healthcare Set to Announce Q4 Earnings on February 11
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy THC?
Source: seekingalpha
- Earnings Announcement Date: Tenet Healthcare (THC) is set to announce its Q4 earnings on February 11 before market open, with a consensus EPS estimate of $4.05, reflecting a 17.7% year-over-year growth, indicating sustained profitability.
- Revenue Expectations: The anticipated revenue for Q4 is $5.47 billion, representing a 7.9% year-over-year increase, which underscores the stable demand for healthcare services and the company's growing market share, further solidifying its industry position.
- Historical Performance: Over the past two years, THC has exceeded EPS estimates 100% of the time and revenue estimates 88% of the time, demonstrating a strong consistency between financial forecasts and actual performance, thereby boosting investor confidence.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 3 upward revisions and 5 downward revisions, while revenue estimates experienced 5 upward revisions with no downward adjustments, indicating a divergence in market perceptions regarding the company's future performance, which may influence investor decisions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy THC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on THC
Wall Street analysts forecast THC stock price to rise
15 Analyst Rating
15 Buy
0 Hold
0 Sell
Strong Buy
Current: 232.260
Low
224.00
Averages
241.36
High
260.00
Current: 232.260
Low
224.00
Averages
241.36
High
260.00
About THC
Tenet Healthcare Corporation is a diversified healthcare services company. The Company's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment is comprised of its acute care and specialty hospitals, a network of employed physicians and ancillary outpatient facilities. The Company's subsidiaries operate approximately 49 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 135 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency departments and micro hospitals. It also provides revenue cycle management and value based care services. The Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 518 ambulatory surgery centers, and 25 surgical hospitals in 37 states. The Company operates a Global Business Center in the Philippines.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Tenet Healthcare Surges to All-Time High After Strong Q4 2025 Earnings
- Strong Earnings Report: Tenet Healthcare reported $5.5 billion in revenue for Q4 2025, reflecting approximately 14% year-over-year growth and exceeding market expectations by $60 million, driven by favorable payer mix and increased disease severity.
- Improved Profitability: The company's non-GAAP EPS rose to $4.70, a 37% increase year-over-year, beating Wall Street forecasts by $0.65, with adjusted EBITDA margin reaching 21.4%, up 70 basis points from the previous year, indicating significant profitability enhancement.
- Positive Market Reaction: Tenet's stock surged nearly 19% on Wednesday, reaching an all-time high, which also boosted shares of major competitors like HCA Healthcare and Universal Health Services, reflecting strong market confidence in its financial performance.
- Future Outlook: Despite projecting a 20% decline in overall enrollments for 2026, Tenet anticipates net operating revenue of $21.9 billion, indicating approximately 4% year-over-year growth, showcasing the company's resilience and market confidence amid challenges.
See More
Tenet Healthcare Reports Strong Q4 2025 Earnings Growth
- Revenue and EBITDA Growth: Tenet Healthcare reported net operating revenues of $21.3 billion and consolidated adjusted EBITDA of $4.57 billion for 2025, reflecting a 14% increase over 2024 and exceeding initial expectations by nearly $500 million, indicating strong financial performance and market demand.
- Strong USPI Performance: The USPI segment achieved a 12% growth in adjusted EBITDA to $2.026 billion in 2025, with double-digit same-store volume growth in total joint replacements, demonstrating the company's sustained competitiveness in the healthcare services sector.
- Share Repurchase Program: Over the past three years, Tenet has repurchased approximately 22% of its outstanding shares for around $2.5 billion, reflecting the company's confidence in its value and creating additional value for shareholders.
- 2026 Guidance: Management projects adjusted EBITDA for 2026 to be between $4.485 billion and $4.785 billion, despite facing a $250 million impact from the expiration of tax credits, indicating a commitment to growth through ongoing M&A and service line expansion.
See More
Diodes Reports Strong Quarterly Earnings, Shares Surge
- Earnings Beat: Diodes reported an adjusted EPS of 34 cents, surpassing market expectations of 32 cents, indicating strong profitability that boosts investor confidence.
- Sales Growth: The company's quarterly sales reached $391.578 million, exceeding the anticipated $385.560 million, suggesting sustained demand for its products that could drive future revenue growth.
- Stock Surge: Diodes shares jumped 31.8% to $81.32 on Wednesday, reflecting a positive market reaction to its earnings report, which may attract more investor interest.
- Market Performance: U.S. stocks were slightly higher, with the Dow Jones gaining around 0.1% on Wednesday, indicating cautious optimism about the economic outlook that could provide a favorable environment for other companies.
See More
Tenet Healthcare Reports 8.9% Revenue Growth in Q4
- Strong Sales Performance: Tenet Healthcare reported fourth-quarter sales of $5.527 billion, reflecting an 8.9% year-over-year increase that surpassed the consensus estimate of $5.472 billion, indicating robust growth in the healthcare services sector.
- Improved Profitability: Adjusted earnings per share rose to $4.70 from $3.44 a year ago, exceeding the consensus of $4.05, which highlights effective cost management and revenue growth strategies implemented by the company.
- Segment Performance: The ambulatory segment saw a 13.8% revenue increase to $1.43 billion, driven by strong growth in same-facility net patient services and expanded service lines, showcasing the company's adaptability in high-demand areas.
- Positive Outlook: Tenet projects 2026 revenues between $21.5 billion and $22.3 billion, above the consensus of $22.21 billion, reflecting confidence in market demand and the company's execution capabilities moving forward.
See More
TENET HEALTHCARE STOCK FALLS 2.2% FOLLOWING LOWER THAN EXPECTED 2026 REVENUE FORECAST
Healthcare Shares Decline: Tenet Healthcare shares have dropped by 2.2%.
Revenue Forecast Adjustment: The company's revenue forecast for 2026 is now projected to be below previous estimates.
See More
Tenet Healthcare Q4 Earnings Exceed Expectations
- Earnings Beat: Tenet Healthcare reported a Q4 non-GAAP EPS of $4.70, surpassing expectations by $0.65, indicating robust profitability growth for the company.
- Significant Revenue Growth: Q4 revenue reached $5.53 billion, up 14% year-over-year, exceeding forecasts by $60 million, reflecting strong performance in patient services and facility acquisitions.
- Surgical Business Strength: The surgical segment's same-facility net patient service revenues increased by 7.2% in Q4, with case volume up 1.6% and net revenue per case rising by 5.5%, driven by higher acuity and favorable payer mix.
- Optimistic Outlook: The FY 2026 adjusted EBITDA is projected to be between $4.485 billion and $4.785 billion, indicating the company's confidence in future performance and potential for continued growth.
See More
Tenet Healthcare Surges to All-Time High After Strong Q4 2025 Earnings
- Strong Earnings Report: Tenet Healthcare reported $5.5 billion in revenue for Q4 2025, reflecting approximately 14% year-over-year growth and exceeding market expectations by $60 million, driven by favorable payer mix and increased disease severity.
- Improved Profitability: The company's non-GAAP EPS rose to $4.70, a 37% increase year-over-year, beating Wall Street forecasts by $0.65, with adjusted EBITDA margin reaching 21.4%, up 70 basis points from the previous year, indicating significant profitability enhancement.
- Positive Market Reaction: Tenet's stock surged nearly 19% on Wednesday, reaching an all-time high, which also boosted shares of major competitors like HCA Healthcare and Universal Health Services, reflecting strong market confidence in its financial performance.
- Future Outlook: Despite projecting a 20% decline in overall enrollments for 2026, Tenet anticipates net operating revenue of $21.9 billion, indicating approximately 4% year-over-year growth, showcasing the company's resilience and market confidence amid challenges.
See More
Tenet Healthcare Reports Strong Q4 2025 Earnings Growth
- Revenue and EBITDA Growth: Tenet Healthcare reported net operating revenues of $21.3 billion and consolidated adjusted EBITDA of $4.57 billion for 2025, reflecting a 14% increase over 2024 and exceeding initial expectations by nearly $500 million, indicating strong financial performance and market demand.
- Strong USPI Performance: The USPI segment achieved a 12% growth in adjusted EBITDA to $2.026 billion in 2025, with double-digit same-store volume growth in total joint replacements, demonstrating the company's sustained competitiveness in the healthcare services sector.
- Share Repurchase Program: Over the past three years, Tenet has repurchased approximately 22% of its outstanding shares for around $2.5 billion, reflecting the company's confidence in its value and creating additional value for shareholders.
- 2026 Guidance: Management projects adjusted EBITDA for 2026 to be between $4.485 billion and $4.785 billion, despite facing a $250 million impact from the expiration of tax credits, indicating a commitment to growth through ongoing M&A and service line expansion.
See More
Diodes Reports Strong Quarterly Earnings, Shares Surge
- Earnings Beat: Diodes reported an adjusted EPS of 34 cents, surpassing market expectations of 32 cents, indicating strong profitability that boosts investor confidence.
- Sales Growth: The company's quarterly sales reached $391.578 million, exceeding the anticipated $385.560 million, suggesting sustained demand for its products that could drive future revenue growth.
- Stock Surge: Diodes shares jumped 31.8% to $81.32 on Wednesday, reflecting a positive market reaction to its earnings report, which may attract more investor interest.
- Market Performance: U.S. stocks were slightly higher, with the Dow Jones gaining around 0.1% on Wednesday, indicating cautious optimism about the economic outlook that could provide a favorable environment for other companies.
See More
Tenet Healthcare Reports 8.9% Revenue Growth in Q4
- Strong Sales Performance: Tenet Healthcare reported fourth-quarter sales of $5.527 billion, reflecting an 8.9% year-over-year increase that surpassed the consensus estimate of $5.472 billion, indicating robust growth in the healthcare services sector.
- Improved Profitability: Adjusted earnings per share rose to $4.70 from $3.44 a year ago, exceeding the consensus of $4.05, which highlights effective cost management and revenue growth strategies implemented by the company.
- Segment Performance: The ambulatory segment saw a 13.8% revenue increase to $1.43 billion, driven by strong growth in same-facility net patient services and expanded service lines, showcasing the company's adaptability in high-demand areas.
- Positive Outlook: Tenet projects 2026 revenues between $21.5 billion and $22.3 billion, above the consensus of $22.21 billion, reflecting confidence in market demand and the company's execution capabilities moving forward.
See More
TENET HEALTHCARE STOCK FALLS 2.2% FOLLOWING LOWER THAN EXPECTED 2026 REVENUE FORECAST
Healthcare Shares Decline: Tenet Healthcare shares have dropped by 2.2%.
Revenue Forecast Adjustment: The company's revenue forecast for 2026 is now projected to be below previous estimates.
See More
Tenet Healthcare Q4 Earnings Exceed Expectations
- Earnings Beat: Tenet Healthcare reported a Q4 non-GAAP EPS of $4.70, surpassing expectations by $0.65, indicating robust profitability growth for the company.
- Significant Revenue Growth: Q4 revenue reached $5.53 billion, up 14% year-over-year, exceeding forecasts by $60 million, reflecting strong performance in patient services and facility acquisitions.
- Surgical Business Strength: The surgical segment's same-facility net patient service revenues increased by 7.2% in Q4, with case volume up 1.6% and net revenue per case rising by 5.5%, driven by higher acuity and favorable payer mix.
- Optimistic Outlook: The FY 2026 adjusted EBITDA is projected to be between $4.485 billion and $4.785 billion, indicating the company's confidence in future performance and potential for continued growth.
See More
